Abstract Introduction Connective Tissue Diseases (CTDs) are systemic autoimmune
conditions characterized by frequent lung involvement. This usually takes the form of …

The interpretation of pulmonary function tests (PFTs) in patients with connective tissue
disease poses considerable difficulties in clinical practice. In established lung disease …

Lung involvement is the most common and serious organ manifestation in patients with
inflammatory rheumatic disease (IRD). The type of pulmonary involvement can differ, but the …

Objective Validated methods for the screening and early diagnosis of systemic sclerosis
(SSc; scleroderma)–related interstitial lung disease (ILD) are needed. The aim of this study …

Objective Interstitial lung disease (ILD) is the leading cause of death in patients with
systemic sclerosis (SSc). Although pulmonary function tests (PFTs) are commonly used to …

Pulmonary function tests (PFTs) allow physicians to evaluate the respiratory function of their
patients in many clinical situations and when there are risk factors for lung disease …

Purpose. Interstitial lung disease (ILD) related to systemic sclerosis (SSc) is assessed with
pulmonary functional tests (PFTs) and semi-quantitative scores based on extent of ILD …

Interstitial lung disease (ILD) is the leading cause of morbidity and mortality in systemic
sclerosis (SSc). We performed a systematic review to characterise the use and validation of …

To explore common patterns of interstitial lung disease (ILD) in symptomless patients with
connective tissue disease (CTD), we applied factorial analysis to determine the relationship …

Objective To determine the prognostic value of pulmonary function test (PFT) trends at 1 and
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …